Equities analysts expect that Ingevity Corp (NYSE:NGVT) will post $232.40 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Ingevity’s earnings. The lowest sales estimate is $232.00 million and the highest is $232.80 million. Ingevity reported sales of $218.50 million in the same quarter last year, which indicates a positive year over year growth rate of 6.4%. The company is scheduled to report its next quarterly earnings report on Wednesday, May 2nd.

On average, analysts expect that Ingevity will report full-year sales of $232.40 million for the current year, with estimates ranging from $1.08 billion to $1.11 billion. For the next year, analysts forecast that the firm will post sales of $1.23 billion per share, with estimates ranging from $1.20 billion to $1.27 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Ingevity.

How to Become a New Pot Stock Millionaire

Ingevity (NYSE:NGVT) last announced its earnings results on Tuesday, February 20th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.36 by $0.09. The firm had revenue of $229.50 million for the quarter, compared to the consensus estimate of $214.94 million. Ingevity had a net margin of 12.99% and a return on equity of 50.74%. The business’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.34 EPS.

Several analysts have issued reports on NGVT shares. Rowe restated an “outperform” rating and issued a $90.00 price target (up from $80.00) on shares of Ingevity in a research report on Thursday, November 30th. Loop Capital lowered shares of Ingevity from a “buy” rating to a “hold” rating and set a $80.00 price target on the stock. in a research report on Tuesday, February 27th. Zacks Investment Research lowered shares of Ingevity from a “strong-buy” rating to a “hold” rating in a research report on Thursday, March 15th. Jefferies Group raised their price target on shares of Ingevity to $92.00 and gave the stock a “buy” rating in a research report on Thursday, March 8th. Finally, SunTrust Banks restated a “buy” rating and issued a $90.00 price target on shares of Ingevity in a research report on Friday, February 23rd. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Ingevity currently has an average rating of “Buy” and a consensus price target of $86.13.

Several institutional investors have recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of Ingevity by 4.9% during the 4th quarter. BlackRock Inc. now owns 5,415,950 shares of the company’s stock valued at $381,661,000 after acquiring an additional 253,722 shares in the last quarter. Channing Capital Management LLC boosted its position in shares of Ingevity by 11.4% during the 4th quarter. Channing Capital Management LLC now owns 1,038,974 shares of the company’s stock valued at $73,216,000 after acquiring an additional 105,991 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Ingevity by 1.0% during the 4th quarter. Bank of New York Mellon Corp now owns 687,517 shares of the company’s stock valued at $48,449,000 after acquiring an additional 6,622 shares in the last quarter. Lazard Asset Management LLC boosted its position in shares of Ingevity by 1.4% during the 4th quarter. Lazard Asset Management LLC now owns 513,444 shares of the company’s stock valued at $36,182,000 after acquiring an additional 6,908 shares in the last quarter. Finally, Copper Rock Capital Partners LLC boosted its position in shares of Ingevity by 29.3% during the 4th quarter. Copper Rock Capital Partners LLC now owns 421,298 shares of the company’s stock valued at $29,946,000 after acquiring an additional 95,350 shares in the last quarter. Institutional investors and hedge funds own 89.94% of the company’s stock.

Ingevity (NYSE:NGVT) opened at $75.10 on Friday. The company has a quick ratio of 1.36, a current ratio of 2.41 and a debt-to-equity ratio of 1.60. The company has a market cap of $3,294.49, a price-to-earnings ratio of 30.35, a P/E/G ratio of 1.95 and a beta of 0.93. Ingevity has a twelve month low of $53.62 and a twelve month high of $82.10.

COPYRIGHT VIOLATION NOTICE: “$232.40 Million in Sales Expected for Ingevity Corp (NGVT) This Quarter” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.watchlistnews.com/232-40-million-in-sales-expected-for-ingevity-corp-ngvt-this-quarter/1959862.html.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Get a free copy of the Zacks research report on Ingevity (NGVT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.